174 related articles for article (PubMed ID: 1829076)
1. Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial.
Davey PG; Williams AH
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():43-50. PubMed ID: 1829076
[TBL] [Abstract][Full Text] [Related]
2. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.
Pauluzzi S; Del Favero A; Menichetti F; Baratta E; Moretti VM; Di Filippo P; Pasticci MB; Guerciolini R; Patoia L; Frongillo RF
J Antimicrob Chemother; 1987 Sep; 20(3):431-8. PubMed ID: 2960643
[TBL] [Abstract][Full Text] [Related]
3. Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria.
de Lalla F; Santoro D; Rinaldi E; Suter F; Cruciani M; Guaglianone MH; Rizzardini G; Pellegata G
J Antimicrob Chemother; 1989 Jan; 23(1):131-42. PubMed ID: 2526109
[TBL] [Abstract][Full Text] [Related]
4. The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.
Webster A; Wilson AP; Williams AH; Treasure T; Grüneberg RN
Postgrad Med J; 1987 Aug; 63(742):621-4. PubMed ID: 2962071
[TBL] [Abstract][Full Text] [Related]
5. Teicoplanin in the treatment of gram-positive-bacterial endocarditis.
Martino P; Venditti M; Micozzi A; Brandimarte C; Gentile G; Santini C; Serra P
Antimicrob Agents Chemother; 1989 Aug; 33(8):1329-34. PubMed ID: 2529815
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia.
Degener JE; Vogel M; Michel MF; Mutsaers MM; Hop WC
J Antimicrob Chemother; 1989 Jun; 23(6):899-904. PubMed ID: 2527224
[TBL] [Abstract][Full Text] [Related]
7. Activity of teicoplanin in localized experimental infections in rats.
Arioli V; Berti M; Candiani G
J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103
[TBL] [Abstract][Full Text] [Related]
8. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.
Gilbert DN; Wood CA; Kimbrough RC
Antimicrob Agents Chemother; 1991 Jan; 35(1):79-87. PubMed ID: 1826594
[TBL] [Abstract][Full Text] [Related]
9. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.
Bibler MR; Frame PT; Hagler DN; Bode RB; Staneck JL; Thamlikitkul V; Harris JE; Haregewoin A; Bullock WE
Antimicrob Agents Chemother; 1987 Feb; 31(2):207-12. PubMed ID: 2952062
[TBL] [Abstract][Full Text] [Related]
11. Glycopeptides in the treatment of staphylococcal infections.
Daschner FD; Kropec A
Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
[TBL] [Abstract][Full Text] [Related]
12. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
Micozzi A; Venditti M; Amadori S; Pulsoni A; Tirindelli C; Martino P
Br J Haematol; 1990 Dec; 76 Suppl 2():19-23. PubMed ID: 2149046
[TBL] [Abstract][Full Text] [Related]
13. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria.
Webster A; Wilson AP; Treasure T; Grüneberg RN
Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800
[TBL] [Abstract][Full Text] [Related]
14. [Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases].
Dureux JB; Canton P; Chavanet P; Chippaux C; Dupeyron JP; Estavoyer JM; Giorgi C; Jaeger A; Jehl F; Kazmierzack A
Pathol Biol (Paris); 1987 May; 35(5):511-5. PubMed ID: 2956564
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
[TBL] [Abstract][Full Text] [Related]
16. Infective endocarditis and glycopeptides.
Pittet D; Harding I
J Infect; 1998 Sep; 37(2):127-35. PubMed ID: 9821086
[TBL] [Abstract][Full Text] [Related]
17. Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.
Galanakis N; Giamarellou H; Vlachogiannis N; Dendrinos C; Daikos GK
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):130-4. PubMed ID: 2968907
[TBL] [Abstract][Full Text] [Related]
18. Spanish experience with teicoplanin.
Fernández-Guerrero M; Gobernado M; Ariza J; Williams A
Scand J Infect Dis Suppl; 1990; 72():38-44. PubMed ID: 2151066
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: a case report.
Saravu K; Mukhopadhyay C; Satyanarayanan V; Pai A; Komaranchath AS; Munim F; Shastry BA; Tom D
Scand J Infect Dis; 2012 Jul; 44(7):544-7. PubMed ID: 22385220
[TBL] [Abstract][Full Text] [Related]
20. Teicoplanin and rifampicin singly and in combination in the treatment of experimental Staphylococcus epidermidis endocarditis in the rabbit model.
Tuazon CU; Washburn D
J Antimicrob Chemother; 1987 Aug; 20(2):233-7. PubMed ID: 2959643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
